Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: J Cardiovasc Pharmacol. 2021 Sep 1;78(3):411–421. doi: 10.1097/FJC.0000000000001082

Figure 2.

Figure 2.

Effects of EGB761 on pAVIC viability under warfarin treatment. pAVICs were treated with warfarin and/or EGB761 at different concentrations (0.1, 0.3, 0.5 or 0.7 mg/ml). Cellular viability was detected by a Cell Counting Kit-8 kit and defined as the percentage of the NC group. n=6. *P<0.05 vs. warfarin group. pAVICs, porcine aortic valve interstitial cells; NC, negative control.